FDA Classifies Inherited Nucleotide Repeat Disorder DNA Test into Class II Special Controls

Summary

The FDA has classified the inherited nucleotide repeat disorder DNA test into Class II special controls, aiming to provide a reasonable assurance of safety and effectiveness while reducing regulatory burdens and enhancing patients' access to innovative devices.